Isolated pathogens and clinical outcomes of adult bacteremia in the emergency department: A retrospective study in a tertiary Referral Center  by Kao, Chih-Hsiang et al.
Journal of Microbiology, Immunology and Infection (2011) 44, 215e221ava i lab le at www.sc iencedi rec t .com
journa l homepage : www.e- jmi i . comORIGINAL ARTICLE
Isolated pathogens and clinical outcomes of adult
bacteremia in the emergency department: A
retrospective study in a tertiary Referral CenterChih-Hsiang Kao a,b, Yau-Chang Kuo a, Chih-Chung Chen a, Yun-Te Chang a,c,
Yao-Shen Chen b, Shue-Ren Wann a,b,*, Yung-Ching Liu b,caDepartment of Emergency Medicine, Kaohsiung Veteran General Hospital, Kaohsiung, Taiwan
bDivision of Infectious Diseases, Department of Internal Medicine, Kaohsiung Veteran General Hospital, Kaohsiung, Taiwan
c Faculty of Medicine, College of Medicine, National Yang-Ming University, Taipei, Taiwan




Health care-associated* Corresponding author. Department
District 81362, Kaohsiung, Taiwan.
E-mail address: chkaou@vghks.gov
1684-1182/$36 Copyright ª 2011, Taiw
doi:10.1016/j.jmii.2011.01.023Background: Approximately two-thirds of the patients with severe sepsis or septic shock are
first encountered in the emergency departments (EDs) of western countries, in which bacter-
emia is present in about 50% of patients with severe sepsis. The situation of bacteremia pre-
senting to the EDs in Taiwan is not well documented. The objective of this study was to
examine the epidemiology and microbiology of bacteremia in adult patients who visited the
ED of a medical center in southern Taiwan.
Methods: A retrospective observational study of the epidemiology and microbiology of bacter-
emia was conducted in the ED of a medical center involving 6,137 adult patients and 13,903
blood cultures.
Results: A total of 831 consecutive patients with 890 episodes of bacteremia were obtained
from January 1 to December 31, 2004, indicating a positive culture rate of 13.5% (1,872/
13,903). Among these episodes, 525 (59%) were defined as true communityeacquired infec-
tions followed by 263 (29.5%) as health careeassociated infections and 102 (11.5%) as nosoco-
mial infections. Of the 972 isolates, 289 (29.7%) were gram-positive species and 683 (70.3%)
were gram-negative species. Urinary tract infections (32.2%, 287/890) were most common in
these patients, with Escherichia coli (30.8%, 299/972) being the most common pathogen.
Bacteremia caused by Staphylococcus aureus was more common in nosocomial than true com-
munityeacquired infections (31.3% vs. 12%) and had significantly higher possibility of resis-
tance to methicillin in infections not purely acquired from community (odds ratio Z 24.92;of Emergency Medicine, Kaohsiung Veteran General Hospital, No. 386, Ta-Chung 1st Rd, Tzou-Ying
.tw (S.-R. Wann).
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216 C.-H. Kao et al.95% confidence interval, 9.88e62.87). The overall crude mortality rate was 21% and nearly half
of the mortalities occurred within 3 days of visiting the ED. All patients discharged inadver-
tently were uneventful (n Z 65, two lost at follow-up).
Conclusions: Categories of bacteremia acquisition was associated with different distribution of
pathogens, antimicrobial resistance, and clinical outcome. Traditional classification might
overestimate the problem of drug resistance in community-acquired infections. The concept
of health careeassociated infection should be introduced to avoid overemphasis of drug-resis-
tant problem in true communityeacquired infection.
Copyright ª 2011, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Fever is usually a sign of infection and is a major complaint
of patients admitted to hospital emergency departments
(EDs).1e4 Usually, it takes about 24e48 hours5 to obtain the
blood culture results in this modern environment, where
bacterial strains have become more and more antibiotic
resistant.6e8 Thus, ED physicians must identify the clinical
and microbiologic features of the febrile patients as soon as
possible to offer the most appropriate antibiotics empiri-
cally on the limited evidence available. The situation will
be more complicated in the ED of tertiary hospitals, which
deal with various nosocomial and community-acquired
infections. Many studies showed clearly the importance of
predicting the pathogenic species and risk factors for
antimicrobial resistance8e10 in the bacteremic patients so
that appropriate empiric antibiotics can be administered.11
However, most of them were either focused on specific
species, diseases, and populations or using an old definition
of bacteremia acquisition in study design.12 Before the
advent of reappraisal of community-acquired bacteremia
advocated by Siegman-Igra et al.,13 many health caree
associated infections that could not be readily classified
into either community or hospital-acquired category then
were recognized as community acquired thus amplifying
the severity of antimicrobial resistance in “true” commu-
nity-acquired infections. Few large-scale comprehensive
studies have had addressed this issue in the field of emer-
gency medicine, particularly in Taiwan. Beside, we were
also interested in the outcome of bacteremic patients,
especially who were discharged inadvertently from the ED.
That was why we conducted this retrospective observa-
tional study to describe the epidemiological and microbio-
logic characteristics of bacteremia in the adult patients
admitted to the ED of a medical center in southern Taiwan
and to review the blood culture results and the prognoses of
these patients.
Materials and methods
Adult patients aged older than 14 years were collected in the
study over a 1-year period, from January 1 to December 31,
2004. All cases enrolled were those who were sent to our ED
and considered urgent to be planned for check for the causes
of febricity. The adult patients were considered to require
blood cultures for empiric antibiotic treatment by a consul-
tant or attending physician on duty. This study protocol wasapproved by the Kaohsiung Veteran General Hospital
(KSVGH) Ethics Committee for human investigation. In the
study period, 67,240 adult patients visited our ED. Among
them, 6,137 adult patients complained of febricity during
7,139 visits, and a total of 13,903 blood cultures were
obtained. Those identified with true bacteremia were
analyzed including demographic data, underlying diseases,
classification of bacteremia acquisition, white blood cell
(WBC) counts, etiologies and isolates of bacteremia, anti-
microbial susceptibility, and clinical outcome. A blood
culture consists of a pair of BACTEC PLUS aerobic/F and
anaerobic/F bottles. Cultures were processed using the
BACTEC9240 system (BectonDickinson, Sparks,MD,USA) and
bacterial species identification (ID) and antimicrobial
susceptibility test were performed using the BD Phoenix
automated microbiology system (Becton Dickinson, Sparks,
MD, USA). The Phoenix ID method uses modified conven-
tional, fluorogenic, and chromogenic substrates. The ID side
contains 45 wells with dried biochemical substrates and 2
fluorescent control wells. The ID broth was inoculated with
bacterial colonies from a pure culture adjusted to a 0.5
McFarland standard by using a CrystalSpec nephelometer (BD
Diagnostics Becton Dickinson, Sparks, MD, USA), according to
the manufacturer’s recommendations. The antimicrobial
susceptibility test side of the combination panel contains up
to 84 wells with dried antimicrobial panels and 1 growth
control well. The assay is a broth-based microdilution test.
The system uses a redox indicator for the detection of
organism growth in the presence of an antimicrobial agent.
The isolates of gram-negative bacteria including extended-
spectrum b-lactamase (ESBL) producing strains, Strepto-
coccal spp and gram-positive bacteria including methicillin-
resistant Staphylococcus aureus (MRSA), and vancomycin-
resistant Enterococcus (VRE) were tested on the BD Phoenix
NMIC/ID-4, SMIC/ID-9, and PMIC/ID-14 panels, respectively,
following manufacturer’s directions.
A bloodstream infection episode was diagnosed after
a positive blood culture result or by any new positive blood
culture result performed more than 48 hours after
a previous positive result. For common contaminants
(coagulase-negative staphylococci, a-hemolytic strepto-
cocci, Corynebacterium spp, Bacillus spp, micrococci, and
Propionibacterium acnes), at least two positive blood
culture results are required for a positive diagnosis. If there
is only one positive blood culture, another positive culture
should be obtained directly from an intravenous catheter or
the clinical significance is otherwise evident.5,14 Poly-
microbial bacteremia was diagnosed after the ID of more
Table 1 Demographics, underlying diseases, and classifi-
cation of 890 adult bacteremic episodes presenting to the







Mean  SD 64.9  16
Median (range) 69 (16e96)
Classification of bacteremia acquisition
Nosocomial 102 (11.5)
Health care associated 263 (29.5)
True community acquired 525 (59.0)
Underlying diseases
Hypertension 383 (30.1)
Diabetes mellitus 300 (23.6)
Malignancy 200 (15.7)
Liver cirrhosisa 130 (10.2)
Uremia 65 (5.1)
Chronic obstructive pulmonary diseases 63 (4.9)
Neurologic deficitb 58 (4.6)
Adult bacteremia in ED 217than one microorganism from a single blood culture or from
different cultures that were taken within 48 hours. Blood-
stream infections were classified following the idea of
proposal Siegman-Igra and colleagues made for the spec-
trum of acquisition of bacteremia.13 Bacteremia in patients
who were recently discharged within 48 hours from the
hospital was classified as “nosocomial.” Bacteremia in
patients who were hospitalized for more than 2 days,
received hemodialysis, intravenous chemotherapy, or
invasive procedures less than 3 months before a bacteremia
episode, or who resided in a nursing home was classified as
“health care associated.” Bacteremia in patients who were
excluded of nosocomial and health careeassociated infec-
tion was classified as “true community acquired.”
A peripheral WBC count of 4,000e10,000/mL, with
neither band nor precursor forms, was considered normal.
All patients’ charts were reviewed by two physicians who
are on the boards of emergency medicine and infectious
diseases. All outcomes were followed for up to 30 days
after ED visit and verified by chart review or telephone
interviews. Crude mortality included all in-hospital death.
Statistical analysis was performed using SPSS version 11.0
(SPSS Inc., Chicago, IL, USA) for Windows. The c2 test was
used to assess the associations among categorical variables.
All tests were two-tailed and p values less than 0.05 were
regarded as significant. The odds ratio (OR) and 95% confi-
dence interval (CI) were calculated for risk estimates.Congestive heart failure 56 (4.4)
Autoimmune disorder 18 (1.4)
a Including alcoholic liver disease.
b Disability in bedridden status.
SD Z standard deviation.Results
Among 13,903 blood cultures, 1,872 (13.5%)were positive for
bacteria. This result represented 1,549 (11.2%) cultures that
were obtained from 831 patients with 890 episodes of
bacteremia. And it left 323 blood cultures (2.3%) as
“contaminated.” The overall incidence of bacteremia in our
ED was 1.3% (890 episodes/67,240 total visits) during 2004.
Among the 831 bacteremia patients, 493 were male
(with 526 episodes, 59.1%) and 338 were female (with 364
episodes, 40.9%). One patient had two episodes of bacter-
emia within one visit, so there were totally 890 episodes in
889 visits. Among these episodes, 525 (59%) were defined as
true community-acquired infections followed by 263
(29.5%) as health careeassociated infections and 102
(11.5%) as nosocomial infections. Demographic data,
disposition of underlying diseases, and classification of
bacteremia acquisition of cases presented with bacteremia
were seen in Table 1. Table 2 demonstrated the etiologies
of these bacteremia, with urinary tract infections (287,
32.2%) being the most common bacterial infections, fol-
lowed by intra-abdominal infection (199, 22.4%) and occult
bacteremia (141, 15.8%). A total of 972 microorganisms
were isolated and classified as bacteremic pathogens (see
Table 3), which included 289 (29.7%) gram-positive and 683
(70.3%) gram-negative organisms. Anaerobic isolates
accounted for 3.7% of all isolates (36/972). The incidence
of polymicrobial bacteremia was 8% (72/890).
The most commonly encountered pathogens in various
etiologies were Escherichia coli in urinary tract infection
(59.2%, 170/287 episodes) and intra-abdominal infection
(44.2%, 88/199 episodes); and Klebsiella pneumoniae in
lower respiratory tract infection (25%, 17/68 episodes).E coli and K pneumoniae accounted for up to 66% (365/538)
pathogens of all urinary tract and intra-abdominal infec-
tions. S aureus were commonly isolated from cardiovas-
cular infection (75%, 55/73 isolates) and soft tissue
infection (35.8%, 39/109 episodes). The pathogens
accounting for occult bacteremia were 59 different species
isolated from 141 episodes and the most common specie, S
aureus, accounted for 19.1% of them.
In all true communityeacquired infections, the most
common pathogen was E coli, accounting for 38.9% of
episodes (204/525). The yield of E coli decreased to 28.5%
(75/263) in health careeassociated infections and 19.6%
(20/102) nosocomial infections, respectively. To the
contrary, S aureus was the most common pathogens in
nosocomial infections (31.3%, 32/102) and its yield
decreased to 15.9% (42/263) and 12% (63/525) in health
careeassociated infections and true communityeacquired
infections, respectively. Non-“true” communityeacquired
bacteremia significantly has a positive association with the
acquisition of MRSA infections (OR Z 24.92; 95% CI,
9.88e62.87, p < 0.05), but not methicillin-susceptible S.
aureus (MSSA). The distribution of common pathogens in
different categories of bacteremia acquisition was
summarized in Table 4.
The resistance of all E coli and K pneumoniae isolates to
cefazolin (a first-generation cephalosporin) was 11.7%
(35/299) and 7.5% (12/161), respectively. Of 150 episodes
Table 2 Case numbers and mortality of different etiolo-
gies accounting for the bacteremic episodes in the Kaoh-
siung Veteran General Hospital emergency department in
2004
Etiologies n (%) Mortality,a
n (%)b
Urinary tract infection 287 (32.2) 29 (10.4)
Intra-abdominal infection 199 (22.4) 39 (20)
Biliary tract infection 104 (11.7) 19 (18.6)
Liver abscess 42 (4.7) 4 (10)
Spontaneous bacterial peritonitis 18 (2.0) 7 (38.9)
Others 35 (3.9) 9 (25.7)
Unknown 141 (15.8) 41 (29.9)
Soft tissue infection 109 (12.3) 16 (15.2)
Respiratory tract infection 76 (8.5) 40 (54.7)
Lower 68 (7.6) 40 (61.5)
Upper 8 (0.9) 0 (0)
Cardiovascular infection 73 (8.2) 20 (27.4)
Central nervous
system infection
5 (0.6) 2 (40)
Total (episodes) 890 (100) 187 (21.6)
a Crude in-hospital mortality.
b Case numbers lost at follow-up: nine in urinary tract infec-
tion, two in liver abscess and biliary tract infection, respec-
tively, four in soft tissue infection and unknown origin,
respectively, and three in lower respiratory tract infection.
Table 3 Isolated pathogens responsible for 890 bacter-
emic episodes in the Kaohsiung Veteran General Hospital
emergency department in 2004
Organisms n (%)
Gram-negative 683 (70.3)
Escherichia coli 299 (30.8)
Sensitivity to first-gen. cephalosporin
Susceptible 264 (27.2)
Resistant 35 (3.6)
ESBL (þ) 17 (1.7)
Klebsiella pneumoniae 161 (16.5)
Sensitivity to first-gen. cephalosporin
Susceptible 149 (15.3)
Resistant 12 (1.2)
ESBL (þ) 9 (0.9)
Proteus mirabilis 34 (3.5)
Salmonella spp 25 (2.6)
Pseudomonas aeruginosa 23 (2.4)
Others 141 (14.5)
Gram-positive 289 (29.7)
Staphylococcus spp 150 (15.4)
S aureus 137 (14.1)
Methicillin susceptible 71 (7.3)
Methicillin resistant 66 (6.8)
Coagulase negative 13 (1.3)
Streptococcus spp 101 (10.4)
S viridans 29 (3.0)
S agalactiae 21 (2.2)
S pneumoniae 17 (1.7)
S pyogens 13 (1.3)
Others 21 (2.2)
Enterococcus spp 27 (2.8)
Others 11 (1.1)
Total (isolates) 972 (100)
ESBL Z extended-spectrum b-lactamase; First-gen. Z first-
generation.
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(47.3%), MRSA accounted for 66 cases (44%), and coagulase-
negative isolates accounted for 13 cases (8.7%). No VRE
isolate was found. The ESBL was detected in 28 isolates
(3.1%), 17 of which were E coli and 9 were K pneumoniae
with only 3 of 28 (10.7%) episodes being true community
acquired.
Six episodes were lost at early follow-up (within 3 days)
and 18 episodes were lost at late follow-up (Days 4e30).
Excluding these episodes, the estimated early mortality rate
(within 3 days) was 11% (97/884) and the late mortality rate
(Days 4e30) was 8% (69/866). The overall in-hospital crude
mortality rate was 21.6% (187/866) (Fig. 1). The mortality of
different etiologies and classifications of bacteremia was
seen in Tables 2 and 4, respectively. Infections with MRSA
showed a higher mortality rate than those with MSSA [29/66
(44%) vs. 15/71 (21%), p< 0.05] (data not shown). Among the
65patientswhoweredischarged inadvertently, 2were lost at
follow-up and the rest of them survived. Most of their etiol-
ogies were unknown origin (47.7%, 31/65) or urinary tract
infection (30.8%, 20/65) and E coli was the most common
pathogens (41.5%, 27/65). The majority of them (70.7%, 46/
65) are true communityeacquired infections. There were
181 (20%) episodes of bacteremia cases presenting with
normal white cell counts that were even more common
(49.2%, 32/65) among those discharged inadvertently. The
early mortality rate (within 3 days) of this group was 4% (7/
177, 4 lost at follow-up).Discussion
Approximately two-thirds of the patients with severe sepsis
or septic shock are first encountered in the EDs,15e17 inwhich
bacteremia is present in about 50% of patients with severe
sepsis. KSVGH is a government medical center built to
provide health care to the community and the populace,who
aremainly the veterans. Somost of our patients were elderly
males, with hypertension (43%), diabetes mellitus (33.7%),
and malignancy (22.5%) being the most common underlying
diseases. With relatively low mortality rate (9.4%), urinary
tract infections (30.6%) were the most common bacterial
infections in our patients. And when taking both intra-
abdominal and urinary tract infections into consideration,
they accounted for more than half of our cases (54.6%, 486/
890) and the most common pathogen identified were E coli.
and K pneumoniae (66%, 365/538). Because the resistance
rate of these pathogen to the commonly used first-line
antibiotic (e.g., first-generation cephalosporins) remained
Table 4 Comparison of mortality, comorbidity, and incidences of common pathogensa among nosocomial, health care-







acquired (n Z 525)
p
n (%) n (%) n (%)
Mortalityb 38 (39.2) 60 (23.3) 83 (16.1) <0.05
Underlying diseases
Diabetes mellitus 32 (31.4) 84 (31.9) 184 (35) 0.59
Malignancy 28 (27.5) 104 (39.5) 68 (13) <0.05
Liver cirrhosis 12 (11.8) 48 (18.3) 70 (13.3) 0.12
Uremia 18 (17.6) 27 (10.3) 20 (3.8) <0.05
Chronic obstructive
pulmonary diseases
19 (18.6) 13 (4.9) 31 (5.9) <0.05
Neurologic deficit 16 (15.7) 24 (9.1) 18 (3.4) <0.05
Congestive heart failure 10 (9.8) 13 (4.9) 33 (6.3) 0.22
Autoimmune disorder 4 (3.9) 8 (3) 6 (1.1) 0.07
Nonec 19 (18.6) 57 (21.7) 195 (37.1) <0.05
Isolates
Escherichia coli 20 (19.6) 75 (28.5) 204 (38.9) <0.05
Klebsiella pneumoniae 9 (8.8) 37 (14.1) 115 (22.0) <0.05
ESBL (þ) 13 (12.7) 12 (4.6) 3 (0.6) <0.05
Staphylococcus aureus 32 (31.3) 42 (16.0) 63 (12.0) <0.05
Methicillin resistant 29 (28.4) 29 (11.0) 8 (1.5) <0.05
Methicillin susceptible 3 (2.9) 13 (4.9) 55 (10.5) <0.05
a Common pathogens: leading three species (a total of 597 isolates, 61.4% of all).
b Five, six, and eleven episodes were lost at follow-up in nosocomial, health care associated, and true communityeacquired
categories, respectively.
c No underlying diseases listed in Table 1 except for hypertension.
ESBL Z extended-spectrum b-lactamase.
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beproper empirical antibiotics for patientswith urinary tract
infection or intra-abdominal infection visiting ED. Bacter-
emia of unknownorigins,whichwas usually themain etiology
of the patients with severe infections18e20 and made the
treatments difficult, were the third commonetiology (15.8%)
in our series. The pathogens accounting for occult bacter-
emia were difficult to predict, because the most commonFigure 1. Cumulative mortality rate of bacteremic patients
following visits to the Kaohsiung Veteran General Hospital
emergency department in 2004.specie, S aureus, accounted for only 19.1% of them, broad
spectrum antimicrobial coverage is thus advised for severe
infections of unknown origins whereas advanced microbio-
logic and epidemiologic studies are warranted to clarify the
relationship between pathogens and occult infections.
It is possible for an ED physician to inadvertently
discharge patients with subsequent bacteremia before
disclosure of culture results, and this would then lead the
physician to the embarrassing situations. Fortunately, these
patients who were inadvertently discharged before prompt
treatments had satisfactory outcomes without complica-
tions, and similar results were also observed by Epstein and
colleagues.21 Generally speaking, the common clues to
advise febrile patients going home on emergency practice
were benign presentation including normal laboratory
result, unknown origin like viral infection without toxic
signs, no comorbidity, and good response to treatment in
observation unit. These probably could explain why most of
the episodes (78.5%, 51/65) discharged inadvertently had
either fever with unknown origin or urinary tract infection
and half of them (49.2%) presenting with normal WBC
counts. However, predictors for their favorable outcome
warrant more comprehensive study design to evaluate.
Other results of the study indicated that febrile patients
with normal WBC counts should also be checked closely
because many bacteremic episodes (181, 20%) occur in
these patients. These cases were tended to be discharged
220 C.-H. Kao et al.without further examinations or treatments. Fortunately,
the early mortality rate (within 3 days) of this group was
lower than average (4% vs. 11%).
An astonishing finding was that over half of the mortal-
ities (97/187, 52%) occurred within 3 days. The effort made
during this period may be crucial to improving the outcome
of bacteremic patients. For example, the early goal-
directed therapy advocated by Rivers et al.,22 was focused
on aggressive management at the early beginning of this
period. A lot of factors were indicated to be associated with
mortality of patents with serious infection, such as clinical
presentation, underlying conditions, etiologies, pathogenic
species and their presence of drug resistance, laboratory
data, and adequacy of antimicrobial therapy.23e25 In our
study, we found the acquisitions of bacteremia were also
associated with mortality, that was the highest fatality rate
noted in nosocomial infections, whereas the lowest in true
communityeacquired infections. Patients in the nosocomial
category had more items of ominous prognostic factors such
as underlying conditions, comorbidity, and presence of
drug-resistant pathogens than those in true communitye
acquired category, which might account for part of this
outcome (Table 4).
In the study, many patients with bacteremic episodes
(41%, 365 of 890) presented to our ED with at least one
nosocomial or health careeassociated factor, presumably
because KSVGH is a tertiary hospital. Organisms isolated
from patients with “true communityeacquired bacteremia”
were invariably more susceptible to antimicrobials.13,26
Recent studies reported the percentage of MRSA in S aureus
bacteremia ranged from 31% to 40%,9,27 which was similar to
the result of our study. And according to the previous
reports,9,27 anti-MRSA antibiotics (rather than penicillinase-
resistant penicillins) should be the first choice for empirical
treatments in the ED if staphylococcus infections are to be
considered. Although up to 56% (37 of 66) MRSA by traditional
classification in our serieswere community acquired,most of
them were actually attributed to health careeassociated
infections (44%, 29/66), not true communityeacquired
infections (12%, 8/66). The result of our study indicated that
the risk for MRSA infection is relatively low if nosocomial or
health careeassociated infection is unlikely,with only 8 of 66
(12%) MRSA bacteremia and 55 of 71 (77%) MSSA bacteremia
being true community acquired. Univariate analysis also
indicated that the non-“true” communityeacquired
bacteremia significantly has a positive association with the
acquisition of MRSA infections (OR Z 24.92; 95% CI,
9.88e62.87, p < 0.05), but not MSSA. One prospective
multicenter study had reported that nafcillin was superior to
vancomycin in efficacy in patients with MSSA bacteremia.28
Furthermore, a delay in the use of an appropriate antibi-
otic (especially glycopeptides) before preliminary microbi-
ological report might not adversely affect the outcome of
patients with MRSA bacteremia.29 Thus, penicillinase-resis-
tant penicillins (such as methicillin) remain as reliable first-
line antibiotics for patients who have not been exposed in
hospital or health care settings.
Regarding the other drug-resistant strain, the incidence
of VRE isolate in our study was none, and that of other
emerging drug-resistant isolates such as ESBL producing
stains was also low (3.1%, 28/890) and most of these (89.2%,
25/28) were isolated from the patients with eithernosocomial or health careeassociated bacteremia. So the
empirical antibiotic treatments used for drug-resistant
isolates should not necessarily be the first-line choice for
true communityeacquired bacteremia in our ED. If health
careeassociated exposure has been excluded, the proba-
bility to acquire drug-resistant bacteremia from the true
community might be low. We believed that the use of the
new classification of bacteremia acquisitions13 would help
to build a distinct epidemiologic, clinical, and bacteriologic
characteristics, as well as distinct antimicrobial suscepti-
bility profiles of the isolates truly acquired from community
we frequently saw in the ED.
Category of bacteremia acquisition was associated with
the distribution of pathogens, trend of antimicrobial resis-
tance, and clinical outcome. The problem of drug resis-
tance in community-acquired infections will be
overestimated if it is defined using traditional classifica-
tion. Purely true communityeacquired drug-resistant
bacteremia might not be that serious as thought, because
a lot of episodes categorized as community acquired before
were attributed to health careeassociated infections. The
concept of health careeassociated bacteremia should be
introduced for an early understanding of the epidemiology
and microbiology of bacteremic patients to avoid over-
emphasis of drug-resistant problem thus prevent antibiotic
abuse in true communityeacquired infection.
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